Application of Genetic Algorithm and U-Net in Brain Tumor Segmentation and Classification: A Deep Learning Approach.


Journal

Computational intelligence and neuroscience
ISSN: 1687-5273
Titre abrégé: Comput Intell Neurosci
Pays: United States
ID NLM: 101279357

Informations de publication

Date de publication:
2022
Historique:
received: 27 06 2022
revised: 01 08 2022
accepted: 16 08 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

The development of unusual cells in the cerebrum causes brain cancer. It is classified primarily into two classes: a noncarcinogenic (benign) type of growth and cancerous (malignant) growth. Early detection of this disease is a quintessential task for all medical practice professionals. For traditional approaches of tumor detections, certain limitations exist. They include less effectiveness, inability to detect due to low-quality processing of images, less dataset for training and testing, less predictive nature to models, and skipping of quintessential stages. All these lead to inaccurate results of tumor detections. To overcome this issue, this paper brings an effective deep learning technique for brain tumor detection with the following stages: (a) data collection from REMBRANDT dataset containing multisequence MRI of 130 patients; (b) preprocessing using conversion to greyscale, skull stripping, and histogram equalization; (c) segmentation uses genetic algorithm; (d) feature extraction using discrete wavelet transform (DWT); (e) particle swarm optimization technique for feature selection; (f) classification using U-Net. Experiment evaluation states that the proposed model (GA-UNET) outperforms (accuracy: 0.97, sensitivity: 0.98, specificity: 0.98) compared to other advanced models.

Identifiants

pubmed: 36156956
doi: 10.1155/2022/5625757
pmc: PMC9499747
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5625757

Informations de copyright

Copyright © 2022 Muhammad Arif et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Med Syst. 2019 Jul 24;43(9):294
pubmed: 31342192
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Brain Inform. 2018 Mar;5(1):23-30
pubmed: 29313301
Comput Biol Med. 2020 Jun;121:103758
pubmed: 32568668
J Med Syst. 2018 Nov 3;42(12):251
pubmed: 30392052
J Healthc Eng. 2022 Feb 10;2022:6952304
pubmed: 35186235
J Healthc Eng. 2022 Jan 10;2022:2693621
pubmed: 35047149
Diagnostics (Basel). 2020 Aug 06;10(8):
pubmed: 32781795
Front Neurosci. 2021 May 28;15:679847
pubmed: 34122001
IEEE Trans Neural Netw Learn Syst. 2018 Nov;29(11):5249-5263
pubmed: 29994642

Auteurs

Muhammad Arif (M)

Department of Computer Science, Superior University, Lahore, Pakistan.

Anupama Jims (A)

Department of Computer Science and Information Technology JAIN (Deemed-to-be University), Bangalore, India.

Ajesh F (A)

Department of Computer Science and Engineering, Sree Buddha College of Engineering, Pattoor Alappuzha, Kerala, India.

Oana Geman (O)

Stefan Cel Mare University of Suceava Romania, Suceava, Romania.

Maria-Daniela Craciun (MD)

Stefan Cel Mare University of Suceava Romania, Suceava, Romania.

Florin Leuciuc (F)

Stefan Cel Mare University of Suceava Romania, Suceava, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH